Antibiofilm Agents for the Treatment and Prevention of Bacterial Vaginosis: A Systematic Narrative Review
Open Access
- 29 April 2024
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 230 (3) , e508-e517
Abstract
Background: Bacterial vaginosis (BV) is difficult to eradicate due to BV biofilms protecting BV bacteria (Gardnerella, Prevotella, and other genera). With the growing understanding of biofilms, we systematically reviewed the current knowledge on the efficacy of anti-BV biofilm agents. Methods: We searched literature in the Scopus, Medline, and Embase databases for empirical studies investigating substances for the treatment of BV biofilms or prevention of their recurrence and their efficacy and/or safety. Results: Of 201 unique titles, 35 satisfied the inclusion criteria. Most studies (89%) reported on preclinical laboratory research on the efficacy of experimental antibiofilm agents (80%) rather than their safety. Over 50% were published within the past 5 years. Agents were classified into 7 groups: antibiotics, antiseptics, cationic peptides, enzymes, plant extracts, probiotics, and surfactants/surfactant components. Enzymes and probiotics were most commonly investigated. Earlier reports of antibiotics having anti-BV biofilm activity have not been confirmed. Some compounds from other classes demonstrated promising anti-BV biofilm efficacy in early studies. Conclusions: Further research is anticipated on successful antibiofilm agents. If confirmed as effective and safe in human clinical trials, they may offer a breakthrough in BV treatment. With rising antibiotic resistance, antibiofilm agents will significantly improve the current standard of care for BV management.Keywords
This publication has 71 references indexed in Scilit:
- In vitro bacterial vaginosis biofilm community manipulation using endolysin therapyBiofilm, 2022
- Lactobacillus helveticus HY7801 ameliorates bacterial vaginosis by inhibiting biofilm formation and epithelial cell adhesion of Gardnerella vaginalisFood Science and Biotechnology, 2022
- Inhibitory effect of Lactobacillus gasseri CCFM1201 on Gardnerella vaginalis in mice with bacterial vaginosisArchives of Microbiology, 2022
- Mechanistic Insights into Immune Suppression and Evasion in Bacterial VaginosisCurrent Microbiology, 2022
- Metastable Iron Sulfides Gram‐Dependently Counteract Resistant Gardnerella Vaginalis for Bacterial Vaginosis TreatmentAdvanced Science, 2022
- Disruption of biofilms and killing of Burkholderia cenocepacia from cystic fibrosis lung using an antioxidant-antibiotic combination therapyInternational Journal of Antimicrobial Agents, 2021
- Polymicrobial Gardnerella biofilm resists repeated intravaginal antiseptic treatment in a subset of women with bacterial vaginosis: a preliminary reportArchives of Gynecology and Obstetrics, 2014
- Disruption of urogenital biofilms by lactobacilliColloids and Surfaces B: Biointerfaces, 2011
- An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazoleAmerican Journal of Obstetrics and Gynecology, 2008
- Effect of Lactobacillus challenge on Gardnerella vaginalis biofilmsColloids and Surfaces B: Biointerfaces, 2007